Xenon Pharmaceuticals Inc (XENE)

38.69 -0.21 (-0.54%) USD  |  NASDAQ  |  Dec 20, 16:00
38.64 -0.05 (-0.13%) After-Hours: 20:00
More

Xenon Pharmaceuticals Enterprise Value: 2.296B for Dec. 20, 2024

Enterprise Value Chart

View Enterprise Value for XENE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Aurinia Pharmaceuticals Inc 944.16M
Edesa Biotech Inc 4.684M
Lexaria Bioscience Corp 31.99M
ESSA Pharma Inc -55.74M
ImmunoPrecise Antibodies Ltd 12.11M

Enterprise Value Related Metrics

Net Income (Quarterly) -62.79M
Total Expenses (Quarterly) 73.68M
EPS Diluted (Quarterly) -0.81
Earnings Yield -7.29%
Normalized Earnings Yield -4.701